Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital (founded in 1916) and New England Deaconess Hospital (founded in 1896). Among independent teaching hospitals, Beth Israel Deaconess Medical Center consistently ranks in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually. BIDMC researchers run more than 850 active sponsored projects and 200 clinical trials. The Harvard-Thorndike General Clinical Research Center, the nation's oldest clinical research laboratory, has been located on this site since 1973.

Website
http://www.bidmc.org/
Wikipedia
http://en.wikipedia.org/wiki/Beth_Israel_Deaconess_Medical_Center

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Alzheimer's disease & dementia

Predicting vulnerability to Alzheimer's disease and delirium

Marked by acute temporary confusion, disorientation and/or agitation, postoperative delirium is the most common post-surgical complication in older adults, striking as many as half of adults older than 65 who undergo high-risk ...

Neuroscience

First evidence of immune response targeting brain cells in autism

Autism spectrum disorders affect one in 59 American children by age eight. With no known quantitative biological features, autism diagnoses are currently based on expert assessments of behavioral symptoms, including impaired ...

Overweight & Obesity

Study: Obesity associated with abnormal bowel habits—not diet

Obesity affects approximately 40 percent of Americans, according to the Centers for Disease Control and Prevention (CDC). While obesity is known to be associated with increased risk of other health conditions—such as heart ...

Cardiology

Polypill holds promise for tackling cardiovascular disease

Heart attacks and strokes are collectively the leading cause of death in most low- and middle-income countries (LMICs) worldwide. Treatment with four drugs—aspirin, a statin, an angiotensin converting-enzyme (ACE)-inhibitor, ...

page 1 from 24